Wednesday - September 10, 2025
University of Cologne: Successful Therapy Confirmed for Newborns With the Fatal Metabolic Disorder MoCD Type A
April 06, 2025
KOLN, Germany, April 6 -- The University of Cologne issued the following news release:

* * *

Successful therapy confirmed for newborns with the fatal metabolic disorder MoCD type A

Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions

The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products